Product image of Irprestan (Irbesartan) supplied by GNH India

Irprestan

Active Ingredient:
Irbesartan
Origin:
EU

Irprestan (Irbesartan)

Irbesartan, the active ingredient in Irprestan, is an Angiotensin II receptor blocker (ARB) presented as an oral tablet for oral administration. It is used to manage high blood pressure and to protect kidney function in patients with diabetic nephropathy, offering a targeted approach to cardiovascular and renal health in adult populations.

GNH India supplies Irprestan as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide with consistent quality and regulatory adherence.

Manufacturer / TM Owner

Actavis Group Ptc Ehf.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Irbesartan acts on the renin‑angiotensin‑aldosterone system to lower blood pressure and protect renal function.

  • Hypertension: reduces systolic and diastolic blood pressure, decreasing cardiovascular risk.
  • Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes.
  • Proteinuria associated with diabetic kidney disease: lowers urinary protein excretion, indicating renal protection.

How It Works

  • Irbesartan selectively blocks the angiotensin II type 1 (AT1) receptor, preventing angiotensin II from inducing vasoconstriction and aldosterone release. This antagonism leads to relaxation of vascular smooth muscle, reduced peripheral resistance, and decreased sodium and water retention, thereby lowering blood pressure and mitigating renal stress.

Side Effects

Common side effects are generally mild and may resolve with continued therapy.

Common Side Effects

  • Dizziness: feeling light‑headed, especially after standing quickly.
  • Headache: mild to moderate head pain.
  • Fatigue: unusual tiredness or lack of energy.
  • Nasal congestion: stuffy or runny nose.
  • Back pain: discomfort in the lower back region.

Serious or Rare Side Effects

  • Angioedema: swelling of the face, lips, tongue, or throat that may impair breathing.
  • Hyperkalemia: elevated potassium levels that can affect heart rhythm.
  • Acute kidney injury: sudden decline in renal function.
  • Hepatic injury: abnormal liver enzyme elevations indicating liver stress.

Precautions & Warnings

Before initiating therapy, consider patient‑specific factors and monitor relevant parameters.

  • Blood pressure monitoring: check regularly to ensure therapeutic targets are met.
  • Renal function assessment: evaluate serum creatinine and eGFR before and during treatment.
  • Electrolyte surveillance: monitor potassium levels, especially if combined with potassium‑sparing agents.
  • Hepatic impairment caution: adjust use in patients with significant liver disease.
  • Pregnancy avoidance: discontinue if pregnancy is confirmed or planned.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Irbesartan may interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Potassium‑sparing diuretics: risk of severe hyperkalemia.
  • ACE inhibitors: additive effect on potassium and renal function.
  • Lithium: increased lithium concentrations, risking toxicity.

Moderate Interactions (Monitor Closely)

  • Thiazide diuretics: may enhance antihypertensive effect, requiring dose adjustment.
  • Rifampin: can reduce irbesartan plasma levels, potentially diminishing efficacy.

Frequently Asked Questions

Irprestan contains irbesartan, an angiotensin II receptor blocker prescribed to lower high blood pressure and to protect kidney function in adults with diabetic nephropathy. It targets the renin‑angiotensin system to achieve cardiovascular and renal benefits.

Irbesartan selectively blocks the AT1 receptor for angiotensin II, preventing vasoconstriction and aldosterone release. This results in relaxed blood vessels, reduced peripheral resistance, and decreased sodium‑water retention, thereby lowering blood pressure and reducing stress on the kidneys.

The appropriate dose of Irprestan is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and any concomitant medications. Dosage adjustments are made according to clinical guidelines and individual needs.

Irprestan is generally contraindicated in pregnancy because angiotensin II receptor blockers can harm the developing fetus. Safety during breastfeeding has not been established, so clinicians usually advise against use unless the benefits outweigh potential risks.

To request Irprestan, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Irprestan belongs to the ARB class, offering similar blood‑pressure‑lowering efficacy to ACE inhibitors but with a lower incidence of cough. Compared with other ARBs, its pharmacokinetic profile and renal‑protective effects in diabetic nephropathy are well documented.

Irprestan should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture and direct sunlight to maintain stability throughout its shelf life.

Irprestan is taken orally, usually as a whole tablet with or without food. Patients should follow the prescriber’s instructions regarding timing and whether the dose should be taken once daily or divided.

Serious risks include angioedema, which can cause airway swelling, severe hyperkalemia leading to cardiac arrhythmias, and acute kidney injury. Patients should seek immediate medical attention if they experience swelling of the face or throat, rapid heartbeat, or significant changes in kidney function.

Irprestan should not be used by individuals with known hypersensitivity to irbesartan or any ARB, pregnant women, or patients with severe hepatic impairment without careful medical supervision. Those with uncontrolled hyperkalemia or severe renal artery stenosis should also avoid this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT